Novozymes A/s(FRA) NZM2

Market Cap€28.69B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€61.44

-0.16%

-0.10Today

Novozymes A/s Financials at a Glance

Market Cap

€28.69B

Revenue (TTM)

€4.30K

Net Income (TTM)

€631.60

EPS (TTM)

€1.35

P/E Ratio

45.41

Dividend

€0.88

Beta (Volatility)

-0.03 (Low)

Dividend

€0.88

Beta (Volatility)

-0.03 (Low)

Price

€61.44

Volume

Open

€61.50

Price

€61.44

Volume

Open

€61.50

Previous Close

€61.44

Daily Range

€61.44 - €61.50

52-Week Range

€44.99 - €61.54

Estimated Earnings Date

N/A

Dividend

€0.88

Beta (Volatility)

-0.03 (Low)

Price

€61.44

Volume

Open

€61.50

Previous Close

€61.44

Daily Range

€61.44 - €61.50

52-Week Range

€44.99 - €61.54

Estimated Earnings Date

N/A

NZM2 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novozymes A/s

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Industry

Chemicals

Sector

Materials

Employees

11,641

CEO

Ester Baiget, MBA

Website

www.novonesis.com

NZM2 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

5.77%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.20%

Dividend Yield

1.44%

Payout Ratio

N/A

Stock Overview

Market Cap

€28.69B

Shares Outstanding

466.25M

Volume

Avg. Volume

169.803

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novozymes A/s Performance Analysis

Novozymes A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 2,359,457,395	17.4%
2023	2023-12-31	EUR 2,402,227,163	1.8%
2024	2024-12-31	EUR 3,833,500,000	59.6%
2025	2025-12-31	EUR 4,157,600,000	8.5%

Novozymes A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 1.77	17.4%
2023	2023-12-31	EUR 1.46	-17.6%
2024	2024-12-31	EUR 0.67	-54.5%
2025	2025-12-31	EUR 1.25	87.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€1.12K

+1.1%

Gross Profit

€621.70

+1.1%

Gross Margin

55.70%

+1.0%

Market Cap

€28.69B

N/A

Market Cap/Employee

€2.21

N/A

Employees

11,641

N/A

Net Income

€171.70

+1.3%

EBITDA

€414.80

+1.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€3.38K

-7.5%

Total Debt

€3.07K

+0.9%

Accounts Receivable

€811.70

+1.1%

Inventory

€836.30

+1.0%

Long Term Debt

€2.83K

+1.0%

Short Term Debt

€237.30

+0.7%

Return on Assets

3.82%

+1.1%

Return on Invested Capital

12.81%

+0.8%

Free Cash Flow

€257.64

+1.0%

Operating Cash Flow

€356.11

+1.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About NZM2

What is the current price of Novozymes A/s?

Novozymes A/s is trading at €61.44 per share.

What is the 52-week range for Novozymes A/s?

Over the past 52 weeks, Novozymes A/s has traded between €44.99 and €61.54.

How much debt does Novozymes A/s have?

As of the most recent reporting period, Novozymes A/s reported total debt of €3.07B.

How much cash does Novozymes A/s have on hand?

Novozymes A/s reported €308.70M in cash and cash equivalents in its most recent financial results.

What is Novozymes A/s’s dividend yield?

Novozymes A/s currently has a dividend yield of 1.44%.

Novozymes A/s(FRA) NZM2

Novozymes A/s Financials at a Glance

NZM2 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novozymes A/s

NZM2 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novozymes A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NZM2

What is the current price of Novozymes A/s?

What is the 52-week range for Novozymes A/s?

How much debt does Novozymes A/s have?

How much cash does Novozymes A/s have on hand?

What is Novozymes A/s’s dividend yield?

Premium Investing Services